Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
The Food and Drug Administration (FDA) has expanded 510(k) clearance for the use of the Xenoview 3T MRI Chest Coil in 3T MRI platforms from GE HealthCare.
The chest coil, which facilitates evaluation of lung ventilation in concert with the hyperpolarized contrast agent Xenoview, was previously cleared by the FDA for use in MRI scanners from Philips and Siemens Healthineers, according to Polarean, the developer of the Xenoview 3T Chest Coil and Xenoview.
Specifically indicated for lung ventilation assessment in adults and pediatric patients 12 years and older, the flexible, single-channel radiofrequency coil is tuned to image Xenon-129 nuclei. Polarean said the clearance facilitates expanded access to hyperpolarized MRI technology for high-risk patients with lung disease.
“Expanding our FDA clearance to include GE HealthCare’s platforms, following our previous clearance for Philips and Siemens systems, ensures that more institutions and clinicians across the U.S. can access our innovative Xenon MRI technology. This expansion further enhances our ability to provide advanced imaging solutions to support patients and clinicians in the detection and ongoing monitoring of lung disease,” added Christopher von Jako, the CEO of Polarean.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.